ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Atlanta, GA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Atlanta, GA, USA:

WATER IV Prostate Cancer (WATER IV PCa)

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Begins enrollment in 1 month
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

Atlanta, Georgia, United States and 12 other locations

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Active, not recruiting
Metastatic Prostate Cancer
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Atlanta, Georgia, United States and 8 other locations

This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...

Enrolling
Prostate Cancer
Drug: ARX517

Phase 1

Ambrx

Atlanta, Georgia, United States and 8 other locations

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

Atlanta, Georgia, United States and 50 other locations

ADT using Degarelix (LHRH antagonist) for men with hormone-sensitive prostate cancer and a rising prostate-specific antige...

Active, not recruiting
Adenocarcinoma of the Prostate
Prostate Cancer
Drug: BMS-986253
Drug: Nivolumab

Phase 1, Phase 2

Mark Stein

Atlanta, Georgia, United States and 3 other locations

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Atlanta, Georgia, United States and 29 other locations

injection for biomarker targeted MR molecular imaging (MRMI) of prostate cancer in patients scheduled for radical prostatectomy....

Enrolling
MRI Scan
Drug: MT218 injection

Phase 1, Phase 2

Songqi Gao

Atlanta, Georgia, United States

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Prednisone
Drug: Placebo

Phase 2, Phase 3

Lilly
Lilly

Atlanta, Georgia, United States and 112 other locations

Eligible patients will be treated with the combination of lenvatinib and pembrolizumab. A cycle equals 21 days and therapy will continue until radiog...

Enrolling
Neuroendocrine Tumors
Prostate Cancer Metastatic
Drug: Pembrolizumab
Drug: Lenvatinib

Phase 2

University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center

Atlanta, Georgia, United States and 4 other locations

may slow or stop the spread of prostate tumor cells that need testosterone to grow. The use of hormone therapy with radiation ther ...

Begins enrollment in 1 month
Stage IVA Prostate Cancer AJCC V8
Stage III Prostate Cancer AJCC V8
Drug: Relugolix
Procedure: Biospecimen Collection

Phase 3

Emory University
Emory University

Atlanta, Georgia, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems